Hutch News

Hutch News

Stories tagged 'non-hodgkin lymphoma'

'It's a great mission'

Partnering with Fred Hutch Global Oncology, Burkitt’s Lymphoma Fund for Africa carries on its founder’s passion

Dec. 23, 2016 | By Mary Engel / Fred Hutch News Service

Dr. Steve Kussick, president of the board for the Seattle-based Burkitt’s Lymphoma Fund for Africa, partners with Fred Hutch Global Oncology to bring cancer care to children in Uganda and Kenya.

View story >


Fertility after cancer: Young women less likely to be told about options

New study finds young male cancer patients twice as likely to be counseled on preserving fertility

July 27, 2015 | By Sabin Russell / Fred Hutch News Service

A new nationwide study by researchers at Fred Hutchinson Cancer Research Center and Seattle Children’s reveals that young male cancer patients were twice as likely as young women to be counseled on ways to preserve their fertility, such as freezing sperm or eggs.

View story >


Eye on a cure: Bandage contact lenses may heal ocular graft-vs.-host disease symptoms

Small study shows big benefit from contacts that soothe debilitating side effects

Oct. 30, 2014 | JoNel Aleccia / Fred Hutch News Service

Small study shows big benefit from contacts that soothe debilitating side effects

View story >


Can’t quit: Nearly 10 percent of cancer patients still smoke

Nearly nine years after diagnosis, bad habits die hard, and some say ‘What’s the point?'

Aug. 6, 2014 | By JoNel Aleccia / Fred Hutch News Service

Nearly nine years after diagnosis, bad habits die hard, and some say ‘What’s the point?'

View story >


Survivors mark milestones with cancerversaries

Tattoos, feats of strength and fundraising are some of the ways patients observe significant dates

April 14, 2014 | By Diane Mapes

Some run marathons, sponsor fundraisers or spend the day in prayer. Others purchase plaques, throw toney soirees or travel to meaningful locales to mark their “cancerversaries,” those key dates that fall a year (or more) out from diagnosis, surgery and/or the end of treatment.

View story >


New drug shows promise in treating slow-growing non-Hodgkin lymphomas

Idelalisib could be on the market later this year, pending FDA approval

Jan. 22, 2014 | By Deborah Bach

New drug, Idelalisib, shows promise in treating slow-growing non-Hodgkins lymphomas.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.